Alyeska Investment Group
IMDZ

Alyeska Investment Group’s Immune Design Corp. IMDZ Stock Holding History

Alyeska Investment Group’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-452,516
Closed -$1.49M – 597
2018
Q1 		$1.49M Sell
452,516
-47,484
-9% -$168K 0.01% 371
2017
Q4 		$1.95M Buy
+500,000
New +$2.72M 0.02% 340
2017
Q2 		– Sell
-165,545
Closed -$1.13M – 625
2017
Q1 		$1.13M Sell
165,545
-1,948
-1% -$11.3K 0.01% 429
2016
Q4 		$921K Buy
167,493
+1,334
+0.8% +$9.42K 0.01% 428
2016
Q3 		$1.26M Buy
+166,159
New +$1.21M 0.01% 405
2014
Q4 		– Sell
-46,833
Closed -$827K – 600
2014
Q3 		$827K Buy
+46,833
New +$593K 0.02% 338

Other funds holding IMDZ

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group's IMDZ Position: Q2 2018 in Review

Alyeska Investment Group sold out of Immune Design Corp. (IMDZ) in Q2 2018, closing a stake of 452,516 shares — an estimated $1.49M sold.

Alyeska Investment Group first reported a position in IMDZ in Q3 2014 and held it in 6 quarters. The position peaked at $1.95M in Q4 2017. 80 funds tracked by Wall St. Rank hold IMDZ as of Q2 2018.

  • Alyeska Investment Group reported no remaining Immune Design Corp. position as of Q2 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 452,516 Immune Design Corp. shares in Q2 2018, an estimated $1.49M.
  • Alyeska Investment Group first reported a position in Immune Design Corp. in Q3 2014 and held it in 6 quarters.
  • Alyeska Investment Group's Immune Design Corp. position peaked at $1.95M in Q4 2017.
  • 80 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2018.

Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.